miR‐193b represses influenza A virus infection by inhibiting Wnt/β‐catenin signalling

Abstract

Due to an increasing emergence of new and drug-resistant strains of the influenza A virus (IAV), developing novel measures to combat influenza is necessary. We have previously shown that inhibiting Wnt/β-catenin pathway reduces IAV infection. In this study, we aimed to identify antiviral human microRNAs (miRNAs) that target the Wnt/β-catenin signalling pathway. Using a miRNA expression library, we identified 85 miRNAs that up-regulated and 20 miRNAs that down-regulated the Wnt/β-catenin signalling pathway. Fifteen miRNAs were validated to up-regulate and five miRNAs to down-regulate the pathway. Overexpression of four selected miRNAs (miR-193b, miR-548f-1, miR-1-1, and miR-509-1) that down-regulated the Wnt/βcatenin signalling pathway reduced viral mRNA, protein levels in A/PR/8/34-infected HEK293 cells, and progeny virus production. Overexpression of miR-193b in lung epithelial A549 cells also resulted in decreases of A/PR/8/34 infection. Furthermore, miR-193b inhibited the replication of various strains, including H1N1 (A/PR/8/34, A/WSN/ 33, A/Oklahoma/3052/09) and H3N2 (A/Oklahoma/309/2006), as determined by a viral reporter luciferase assay. Further studies revealed that β-catenin was a target of miR-193b, and β-catenin rescued miR-193b-mediated suppression of IAV infection. miR-193b induced G0/G1 cell cycle arrest and delayed vRNP nuclear import. Finally, adenovirus-mediated gene transfer of miR-193b to the lung reduced viral load in mice challenged by a sublethal dose of A/PR/8/34. Collectively, our findings suggest that miR-193b represses IAV infection by inhibiting Wnt/β-catenin signalling. KEYWORDS cell cycle arrest, influenza A virus, microRNA, miR-193b, vRNP nuclear import, Wnt/β-catenin signaling

Experimental Models to Study COVID-19 Effect in Stem Cells

“…Virulent viruses can suppress β-catenin-dependent transcription by misusing the RIG-I/NF-κB signaling cascade that is induced in the course of infection by viral RNA [ 36 ], and we hypothesize that COVID-19 is similar to other viruses in this regard [ 37 ]. Therefore, activation of Wnt/β-catenin signaling could be a major therapeutic intervention in the context of viral infection [ 38 ] if implemented early in the infectious lifecycle ( Figure 2 ) where the immediate check on viral spread can happen before the adaptive immune response has time to develop several days after infection. More specifically, type I interferons are a critical part of our innate immune defense as they induce an array of proteins that interfere with virus replication in order to restrict and limit viral spread from cell to cell [ 39 ] in that early window before the adaptive immune response can even take effect.…”

miR-149-3p reverses CD8 + T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells

“…Aberrant expression of miRNAs is involved in the pathogenesis of various diseases including cancer, cardiac hypertrophy, respiratory diseases and others [21][22][23][24]. Depending on the circumstances, miRNAs can either promote or suppress tumour formation by modulating cell proliferation, death, invasion, metastasis and/or angiogenesis [25][26][27]. In immune cells within the TME, miRNAs can stimulate or suppress antitumour immunity by controlling immune regulatory molecules in both tumours and immune cells [28].…”

Identification of lncRNA‐155 encoded by MIR155HG as a novel regulator of innate immunity against influenza A virus infection

“…Recently, a great attention has been paid to noncoding RNAs (ncRNAs) as they have been extensively reported to play various key roles in the regulation of cellular response and metabolic pathways (Cech & Steitz, 2014;Yang et al, 2019). ncRNAs include various categories of RNAs, among them, long noncoding RNAs (lncRNAs) are the most substantial ncRNAs regulating the immune response to viral infection Li et al, 2015;Maarouf, Rai, Goraya, & Chen, 2018;Ouyang et al, 2014;Ouyang, Hu, & Chen, 2016).…”